Airway diseases
Pulmonary vascular diseases
PG19 Postgraduate course
Heart-lung interaction
Clinical
What the chest physician has to know
Registration for this session is additional to the congress registration fee and is €171 on site.
Aims : Access educational materials here to describe the diagnosis and treatment of heart failure and coronary artery disease; to delineate how lung disease hinders the diagnostic process, including physical examination, biomarkers, chest X ray and echocardiography; to discuss the duration of treatment following unprovoked pulmonary embolism, the need to pause anticoagulation before invasive procedures, and the management of bleeding given that new oral anticoagulation has changed, improved and complicated the treatment of acute and chronic pulmonary embolism.
Target audience :
Clinical researcher, General practitioner, Nurse, Patient, Physiologist, Scientist (basic, translational), Student, Trainee
Methods :
General respiratory patient care, Physiology
14:00
Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation?
I. Stone(London, United Kingdom)
COI
-
Description
1
209
14:30
Heart failure and coronary artery disease in lung disease
S. Andreas(Immenhausen, Germany)
COI
-
Description
2
210
15:00
Group assignment
I. Stone(London, United Kingdom)
COI
S. Andreas(Immenhausen, Germany)
COI
3
211
16:00
Diagnosing pulmonary embolism in lung disease
H. Olschewski(Graz, Austria)
COI
-
Description
5
213
16:30
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation
M. Lankeit(Mainz, Germany)
COI
-
Description
6
214
17:00
Group assignment
H. Olschewski(Graz, Austria)
COI
M. Lankeit(Mainz, Germany)
COI
7
215
. . .